Warning Letter Roundup: FDA Warns Five Firms for Quality Deficiencies

The FDA issued warnings to the following facilities in Australia, Korea, the European Union and the United States for deficiencies in records, documentation, GMPs, testing and validation:
Source: Drug GMP Report